Chemicals · Founded 1973 · www.sncl.com · BSE 506642 · NSE SADHANA NITR · ISIN INE888C01040
No Notes Added Yet
Business
Sadhana Nitro Chem Ltd. (SNC) is an Indian manufacturer of specialty chemicals, primarily focusing on nitroaromatics and their derivatives. The company produces a range of intermediates used in various industries, including dyes, pigments, agrochemicals, pharmaceuticals, and optical brightening agents. Key products include Nitrobenzene, Metanilic Acid, Aniline-2,5-Disulphonic Acid, and other sulphone derivatives. SNC's core business model revolves around manufacturing these complex chemical intermediates using advanced processes and selling them to industrial clients globally, thereby generating revenue.
Revenue Mix
Sadhana Nitro Chem primarily operates within the specialty chemicals segment. While granular revenue breakdown across specific product lines is not always publicly segmented, the company's product portfolio can be broadly categorized into:
Nitroaromatics: Base chemicals like Nitrobenzene.
Specialty Intermediates: Derivatives such as Metanilic Acid (where SNC is a prominent global player), Aniline-2,5-Disulphonic Acid, and other complex sulphone derivatives.
These products cater to a diverse set of end-use industries, reducing dependence on a single sector.
Industry
The Indian chemicals industry, particularly the specialty chemicals segment, is experiencing growth, driven by domestic demand and global supply chain diversification (China+1 strategy). The industry is competitive, with both domestic and international players. Sadhana Nitro Chem holds a niche and strong position in specific products, notably being one of the leading manufacturers of Metanilic Acid globally. Its positioning is characterized by process expertise in nitroaromatics and derivatives, catering to high-quality requirements of various downstream industries.
MOAT
Sadhana Nitro Chem's competitive advantages include:
Process Expertise: Long-standing experience and established manufacturing processes for complex nitroaromatic chemistry and sulfonation, leading to efficient production.
Backward Integration: Strategic backward integration for key raw materials or intermediates (e.g., Nitrobenzene) helps in cost control and supply security.
Niche Product Leadership: A strong global position in specific products like Metanilic Acid, indicating specialized knowledge and scale advantages in these areas.
Established Customer Relationships: Long-term relationships with diverse clients in various industries globally.
Growth Drivers
Key factors that can drive growth for Sadhana Nitro Chem over the next 3-5 years include:
Capacity Expansions: Commissioning of new production capacities for existing products and diversification into new, higher-value specialty chemicals.
Increased Demand from End-User Industries: Sustained growth in sectors like pharmaceuticals, agrochemicals, and dyes, which are major consumers of SNC's intermediates.
"China+1" Strategy: Global manufacturers seeking to diversify their supply chains away from China, potentially increasing export opportunities for Indian specialty chemical companies like SNC.
Product Diversification: Introduction of new specialty chemicals to cater to evolving market needs and expand the product basket.
Import Substitution: Potential to capture domestic market share currently served by imports.
Risks
Raw Material Price Volatility: Fluctuations in prices of key raw materials (often crude oil derivatives) can impact production costs and profit margins.
Environmental Regulations: Stringent environmental norms and compliance costs can pose operational and financial challenges.
Intense Competition: The specialty chemicals sector is competitive, leading to potential pricing pressure and margin erosion.
End-User Industry Cyclicality: Demand for SNC's products is tied to the performance of downstream industries, which can be cyclical.
Currency Fluctuations: As an exporter and importer, the company is exposed to foreign exchange rate volatility.
Project Execution Risk: Delays or cost overruns in planned capacity expansion projects could impact growth targets.
Management & Ownership
Sadhana Nitro Chem is a promoter-led company. The management team has significant experience within the chemical industry. The promoter group, including Mr. Ashok G. Gothi, holds a substantial ownership stake, indicating alignment of interests with the company's long-term performance. The ownership structure generally features a significant promoter holding alongside institutional and public shareholding.
Outlook
Sadhana Nitro Chem's outlook is cautiously optimistic, balancing growth opportunities with inherent industry risks. The company stands to benefit from its established position in niche nitroaromatics, increasing demand from diverse end-user industries, and global supply chain shifts favoring Indian manufacturers. Planned capacity expansions and product diversification efforts could fuel future growth. However, this positive trajectory is subject to managing the volatility of raw material prices, navigating stringent environmental regulations, and facing competitive pressures. Sustained demand for its specialty intermediates and successful execution of growth strategies will be key determinants of its performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 65 | 36 | 43 | 37 | 49 | 28 | 3 | 10 | 9 | 27 |
| Other Income | 2 | 0 | 1 | 0 | -0 | 4 | -0 | 1 | 3 | 4 |
| Total Income | 67 | 36 | 44 | 38 | 49 | 33 | 2 | 11 | 12 | 31 |
| Total Expenditure | 55 | 26 | 35 | 26 | 36 | 26 | 20 | 25 | 32 | 25 |
| Operating Profit | 12 | 10 | 9 | 12 | 13 | 6 | -17 | -14 | -19 | 6 |
| Interest | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 7 | 11 | 3 |
| Depreciation | 3 | 4 | 4 | 3 | 4 | 5 | 4 | 4 | 4 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 4 | 2 | 1 | 4 | 5 | -2 | -26 | -25 | -34 | -0 |
| Provision for Tax | 4 | 1 | 1 | 1 | 1 | -0 | -0 | 0 | -1 | 0 |
| Profit After Tax | 1 | 1 | 0 | 3 | 4 | -2 | -26 | -25 | -34 | -1 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 1 | 0 | 3 | 4 | -2 | -26 | -25 | -34 | -1 |
| Adjusted Earnings Per Share | 0 | 0 | 0 | 0 | 0 | -0 | -0.2 | -0.2 | -0.1 | -0 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 36 | 55 | 114 | 267 | 106 | 103 | 132 | 143 | 190 | 166 | 50 | 49 |
| Other Income | 0 | 0 | 0 | 1 | 2 | 5 | 5 | 2 | 4 | 2 | 9 | 8 |
| Total Income | 36 | 56 | 114 | 268 | 108 | 108 | 137 | 145 | 194 | 167 | 58 | 56 |
| Total Expenditure | 34 | 47 | 78 | 147 | 77 | 80 | 117 | 122 | 149 | 123 | 103 | 102 |
| Operating Profit | 2 | 9 | 37 | 122 | 31 | 28 | 20 | 23 | 45 | 44 | -45 | -44 |
| Interest | 5 | 6 | 7 | 12 | 3 | 3 | 5 | 10 | 17 | 18 | 26 | 26 |
| Depreciation | 2 | 2 | 2 | 3 | 6 | 6 | 6 | 8 | 15 | 15 | 16 | 15 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -5 | 1 | 28 | 107 | 22 | 19 | 9 | 6 | 13 | 12 | -87 | -85 |
| Provision for Tax | 0 | 0 | -3 | 31 | 8 | 3 | 3 | 2 | 9 | 4 | -1 | -1 |
| Profit After Tax | -5 | 1 | 31 | 76 | 15 | 16 | 6 | 3 | 4 | 8 | -86 | -86 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -5 | 1 | 31 | 76 | 15 | 16 | 6 | 3 | 4 | 8 | -86 | -86 |
| Adjusted Earnings Per Share | -0 | 0 | 0.3 | 0.7 | 0.7 | 0.1 | 0.1 | 0 | 0 | 0.1 | -0.3 | -0.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -70% | -30% | -13% | 3% |
| Operating Profit CAGR | -202% | NAN% | NAN% | NAN% |
| PAT CAGR | -1175% | NAN% | NAN% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -15% | -50% | -20% | 23% |
| ROE Average | -24% | -6% | -2% | 22% |
| ROCE Average | -11% | 1% | 3% | 24% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 7 | 10 | 46 | 105 | 116 | 130 | 160 | 226 | 227 | 281 | 454 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 18 | 7 | 3 | 2 | 28 | 35 | 60 | 129 | 140 | 44 |
| Other Non-Current Liabilities | 2 | 2 | -1 | 4 | 12 | 8 | 13 | 13 | 19 | 18 | 12 |
| Total Current Liabilities | 59 | 52 | 84 | 64 | 86 | 138 | 178 | 128 | 158 | 198 | 147 |
| Total Liabilities | 68 | 83 | 136 | 177 | 216 | 304 | 386 | 426 | 532 | 637 | 658 |
| Fixed Assets | 29 | 37 | 50 | 76 | 84 | 78 | 75 | 144 | 156 | 159 | 163 |
| Other Non-Current Assets | 10 | 12 | 28 | 5 | 20 | 43 | 93 | 59 | 111 | 203 | 230 |
| Total Current Assets | 29 | 34 | 59 | 96 | 112 | 183 | 219 | 224 | 265 | 275 | 265 |
| Total Assets | 68 | 83 | 136 | 177 | 216 | 304 | 386 | 426 | 532 | 637 | 658 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 | -15 | 0 | 5 | -4 | 4 | 6 | -13 | -39 | -55 |
| Cash Flow from Operating Activities | -1 | 9 | 35 | 53 | -17 | 1 | -5 | -38 | -2 | 48 | -29 |
| Cash Flow from Investing Activities | -0 | -1 | -6 | -25 | -22 | -23 | -39 | -53 | -65 | -89 | -46 |
| Cash Flow from Financing Activities | 2 | -25 | -13 | -23 | 30 | 30 | 46 | 72 | 41 | 25 | 93 |
| Net Cash Inflow / Outflow | 1 | -16 | 16 | 5 | -9 | 7 | 2 | -19 | -26 | -16 | 18 |
| Closing Cash & Cash Equivalent | 1 | -15 | 0 | 5 | -4 | 4 | 6 | -13 | -39 | -55 | -37 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.04 | 0 | 0.27 | 0.66 | 0.75 | 0.14 | 0.05 | 0.03 | 0.03 | 0.06 | -0.29 |
| CEPS(Rs) | -0.03 | 0.02 | 0.29 | 0.68 | 1.05 | 0.19 | 0.11 | 0.09 | 0.16 | 0.19 | -0.24 |
| DPS(Rs) | 0 | 0 | 0.01 | 0.03 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0.03 | 0 |
| Book NAV/Share(Rs) | -0.02 | 0.09 | 0.4 | 0.9 | 5.95 | 1.05 | 1.09 | 1.82 | 1.82 | 2.22 | 1.5 |
| Core EBITDA Margin(%) | 5.24 | 14.69 | 31.72 | 45.13 | 27.79 | 22.68 | 11.1 | 14.81 | 21.61 | 25.57 | -106.82 |
| EBIT Margin(%) | 0.41 | 12.18 | 30.3 | 44.51 | 24.16 | 21.43 | 10.23 | 10.75 | 15.85 | 17.53 | -122.47 |
| Pre Tax Margin(%) | -13.41 | 0.89 | 24.49 | 40.02 | 21.06 | 18.11 | 6.77 | 3.94 | 6.75 | 6.95 | -175.73 |
| PAT Margin (%) | -13.41 | 0.89 | 27.19 | 28.4 | 13.81 | 15.45 | 4.73 | 2.22 | 2.15 | 4.57 | -173.99 |
| Cash Profit Margin (%) | -7.97 | 4.27 | 28.87 | 29.48 | 19.29 | 21.47 | 9.36 | 7.52 | 9.99 | 13.74 | -141.12 |
| ROA(%) | -7.39 | 0.67 | 28.41 | 48.47 | 7.47 | 6.13 | 1.8 | 0.78 | 0.85 | 1.29 | -13.35 |
| ROE(%) | 0 | 12.68 | 110.55 | 101.05 | 13.28 | 13.42 | 5.03 | 1.85 | 1.88 | 3.09 | -24.1 |
| ROCE(%) | 0.38 | 15.89 | 64.42 | 135.94 | 18.57 | 12.04 | 5.85 | 5.09 | 7.65 | 6.14 | -11.47 |
| Receivable days | 99.95 | 74.35 | 40.86 | 21.1 | 76.8 | 138.04 | 124.35 | 135.49 | 184.17 | 274.09 | 937.69 |
| Inventory Days | 91.77 | 81.25 | 60.74 | 42.99 | 159.67 | 209.05 | 231.33 | 275.65 | 221.43 | 275.64 | 857.46 |
| Payable days | 402.06 | 317.94 | 206.5 | 94.04 | 198.93 | 217.55 | 173.94 | 202.46 | 144.59 | 238.99 | 321.45 |
| PER(x) | 0 | 76.15 | 6.55 | 8.15 | 2.41 | 22.46 | 414.52 | 728.37 | 378.24 | 73.72 | 0 |
| Price/Book(x) | -6.67 | 3.72 | 4.44 | 5.93 | 0.3 | 2.96 | 20.42 | 10.65 | 7.09 | 2.05 | 0.92 |
| Dividend Yield(%) | 0 | 0 | 0.46 | 0.6 | 0 | 0 | 0.11 | 0.13 | 0.24 | 0.59 | 0 |
| EV/Net Sales(x) | 1.63 | 1.33 | 1.86 | 2.31 | 10.28 | 4.17 | 20.33 | 17 | 9.24 | 4.73 | 10.06 |
| EV/Core EBITDA(x) | 27.07 | 8.3 | 5.78 | 5.07 | 34.7 | 15.2 | 136.74 | 105.89 | 39.01 | 17.72 | -11.22 |
| Net Sales Growth(%) | -25.58 | 54.02 | 106.64 | 134.29 | -60.28 | -2.84 | 27.82 | 8.82 | 32.59 | -12.89 | -70 |
| EBIT Growth(%) | -98.12 | 4434.64 | 400.18 | 243.07 | -78.44 | -13.82 | -38.97 | 14.34 | 95.41 | -3.65 | -309.63 |
| PAT Growth(%) | -224.84 | 110.28 | 6019.54 | 143.91 | -80.68 | 8.69 | -60.91 | -48.94 | 28.43 | 85.16 | -1243.5 |
| EPS Growth(%) | -224.84 | 110.28 | 5944.17 | 143.91 | 14.22 | -81.61 | -60.91 | -50.6 | 28.45 | 80.62 | -572.45 |
| Debt/Equity(x) | 4.7 | 3.43 | 0.34 | 0.08 | 0.4 | 0.69 | 0.84 | 0.61 | 1.01 | 0.87 | 0.24 |
| Current Ratio(x) | 0.49 | 0.65 | 0.7 | 1.5 | 1.31 | 1.32 | 1.23 | 1.75 | 1.68 | 1.39 | 1.81 |
| Quick Ratio(x) | 0.33 | 0.34 | 0.44 | 0.92 | 0.7 | 0.84 | 0.66 | 0.84 | 0.95 | 0.71 | 1.14 |
| Interest Cover(x) | 0.03 | 1.08 | 5.21 | 9.91 | 7.8 | 6.45 | 2.95 | 1.58 | 1.74 | 1.66 | -2.3 |
| Total Debt/Mcap(x) | 2.14 | 0.92 | 0.08 | 0.01 | 0.22 | 0.23 | 0.04 | 0.06 | 0.14 | 0.42 | 0.27 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.48 | 65.47 | 65.11 | 64.9 | 56.73 | 29.97 | 29.97 | 60.9 | 60.9 | 59.55 |
| FII | 0 | 0 | 0 | 0.05 | 0.04 | 0.04 | 0.14 | 0 | 0.04 | 0.04 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.03 | 0.03 |
| Public | 34.5 | 34.51 | 34.88 | 35.04 | 43.22 | 69.99 | 69.88 | 39.09 | 39.03 | 40.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 16.18 | 16.18 | 21.45 | 21.38 | 18.69 | 9.87 | 9.87 | 180.56 | 180.56 | 180.56 |
| FII | 0 | 0 | 0 | 0.02 | 0.01 | 0.01 | 0.05 | 0.01 | 0.12 | 0.12 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.08 |
| Public | 8.52 | 8.53 | 11.49 | 11.54 | 14.24 | 23.05 | 23.02 | 115.9 | 115.71 | 122.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24.71 | 24.71 | 32.94 | 32.94 | 32.94 | 32.94 | 32.94 | 296.47 | 296.47 | 303.22 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -70% | -30% | -13% | +3% |
| Operating Profit CAGR | -202% | 0% | 0% | 0% |
| PAT CAGR | -1175% | 0% | 0% | — |
| Share Price CAGR | -15% | -50% | -20% | +23% |
| ROE Average | -24% | -6% | -2% | +22% |
| ROCE Average | -11% | +1% | +3% | +24% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.48 | 65.47 | 65.11 | 64.9 | 56.73 | 29.97 | 29.97 | 60.9 | 60.9 | 59.55 |
| FII | 0 | 0 | 0 | 0.05 | 0.04 | 0.04 | 0.14 | 0 | 0.04 | 0.04 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.03 | 0.03 |
| Public | 34.5 | 34.51 | 34.88 | 35.04 | 43.22 | 69.99 | 69.88 | 39.09 | 39.03 | 40.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 16.18 | 16.18 | 21.45 | 21.38 | 18.69 | 9.87 | 9.87 | 180.56 | 180.56 | 180.56 |
| FII | 0 | 0 | 0 | 0.02 | 0.01 | 0.01 | 0.05 | 0.01 | 0.12 | 0.12 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.08 |
| Public | 8.52 | 8.53 | 11.49 | 11.54 | 14.24 | 23.05 | 23.02 | 115.9 | 115.71 | 122.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24.71 | 24.71 | 32.94 | 32.94 | 32.94 | 32.94 | 32.94 | 296.47 | 296.47 | 303.22 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.